Informe completo: Molecular tests for detection of PIK3CA mutations in men and postmenopausal women with HR+/HER2–, locally advanced or metastatic breast cancer
Objetivo: To summarise available evidence on the analytical validity, the clinical validity, and the clinical utility of molecular tests, for the detection of PIK3CA mutations.
Autoría: Norwegian Institute of Public Health (NIPH)
Idioma: inglés
Fuente: INAHTA
Año de publicación: 2022